Biocardia Lifesciences
San Carlos, US · Delaware corporation
Founders & leadership
Reported raises · per SEC filings
Form D private placements$8.7M disclosed across 2 rounds · 2016
▶$4.4MraisedNov 2016 · 18 investors · Other Health CareRule 506(b)
▶$4.4MraisedNov 2016 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- DAVID MCCLUNGExecutive Officer
- PETER ALTMANExecutive Officer, Director, Promoter
- Offering amount
- $6.5M
- Amount sold
- $4.4M
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.4MraisedNov 2016 · 18 investors · Other Health CareRule 506(b)
▶$4.4MraisedNov 2016 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- DAVID MCCLUNGExecutive Officer
- PETER ALTMANExecutive Officer, Director, Promoter
- Offering amount
- $6.5M
- Amount sold
- $4.4M
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Biocardia Lifesciences raised?
- Biocardia Lifesciences has disclosed $8.7M raised across 2 rounds.
- Where is Biocardia Lifesciences headquartered?
- Biocardia Lifesciences is headquartered in San Carlos, US.